Description:Rabbit polyclonal antibody to PDPK1 (Phospho-S241)Immunogen:KLH-conjugated synthetic phosphopeptide corresponding to residues surrounding S241 of human PDPK1 protein. The exact sequence is proprietary.Purification:The antibody was purified by immunogen affinity chromatography.Clonality:PolyclonalForm:Liquid in 0.42% Potassium phosphate, 0.87% Sodium chloride, pH 7.3, 30% glycerol, and 0.01% sodium azide.Dilution:WB (1/500 - 1/1000), IH (1/50 - 1/100)Gene Symbol:PDPK1Alternative Names:PDK1; 3-phosphoinositide-dependent protein kinase 1; hPDK1
Entrez Gene (Human):
5170;
Entrez Gene (Mouse):
18607;
Entrez Gene (Rat):
81745;
SwissProt (Human):
O15530;
SwissProt (Mouse):
Q9Z2A0;
SwissProt (Rat):
O55173;
Storage/Stability:Shipped at 4°C. Upon delivery aliquot and store at -20°C for one year. Avoid freeze/thaw cycles.
-
Western blot analysis of PDPK1 (Phospho-S241) expression in mouse liver (A), mouse lung (B), rat liver (C) whole cell lysates. (Predicted band size: 63 kD; Observed band size: 63 kD)
-
Immunohistochemical analysis of PDPK1 (Phospho-S241) staining in human breast cancer formalin fixed paraffin embedded tissue section. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0). The section was then incubated with the antibody at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.
Lkb1 deficiency causes prostate neoplasia in the mouse
A reduction in Pten tumor suppressor activity promotes ErbB-2-induced mouse prostate adenocarcinoma formation through the activation of signaling cascades downstream of PDK1
Small-molecule inhibitors of phosphatidylinositol 3-kinase/Akt signaling inhibit Wnt/beta-catenin pathway cross-talk and suppress medulloblastoma growth